Sjöberg Prize
(Redirected from The Sjöberg Prize)
| The Sjöberg Prize | |
|---|---|
| Awarded for | Significant contributions to cancer research |
| Country | Sweden |
| Presented by | Royal Swedish Academy of Sciences |
| First awarded | 2017 |
| Website | Swedish English |
The Sjöberg Prize is an award aimed at individuals or research groups that have made significant contributions to cancer research. The prize, which is international, is planned to be awarded annually. It consists of a 100,000 US dollars of free disposal and 900,000 dollars to fund future research making up a total of one million US dollars. The prize money increases to counteract inflation.[1] The Prize is funded by The Sjöberg Foundation, and the Royal Swedish Academy of Sciences is responsible for deciding upon the Sjöberg Laureates. The Foundation was founded in 2016, and the first prize was announced on 14 February 2017.[2]
Laureates
[edit]| Year | Image | Laureate | Nationality | Work | Ref. |
|---|---|---|---|---|---|
| 2017 | .JPG)
|
James P. Allison | American | “Pioneering studies of cellular processes which led to the development of new effective cancer drugs” | [1][3] |
|
Tony Hunter | British-American | |||
| 2018 | 
|
Zhu Chen | Chinese | “for the clarification of molecular mechanisms and the development of a revolutionary treatment for acute promyelocytic leukaemia” | [4] |
|
Anne Dejean | French | |||
| Hugues de Thé | French | ||||
| 2019 | Dennis Slamon | American | “for their groundbreaking contributions to the clinical development of targeted therapy directed against genetic aberrations in cancer.” | [5] | |
|
Brian Druker | American | |||
| 2020 | 
|
Michael N. Hall | American | “for their discovery of mTOR and its role in the control of cell metabolism and growth.” | [6] |
| David M. Sabatini | American | ||||
| 2021 | Benjamin L. Ebert | American | “for his discovery of the mode of action of lenalidomide in the treatment of haematological disorders” | [7] | |
| 2022 | Arul Chinnaiyan | American | "for the discovery of recurrent gene fusions in prostate cancer" | [8] | |
| 2023 | Kevan Shokat | American | “for discoveries that enable the inhibition of mutated K-Ras in cancer treatment” | [9] | |
| 2024 | Catherine J. Wu | American | “for discoveries concerning tumour neoantigens and the immune response to tumour cells as a basis for cancer vaccine development” | [10] |
References
[edit]- ^ a b "The Sjöberg prize". sjobergstiftelsen.se. Sweden: The Sjöberg Foundation. 2016. Archived from the original on 4 November 2017. Retrieved 5 November 2017.
- ^ "About the Sjöberg Prize". kva.se. Sweden: Royal Swedish Academy of Sciences. Retrieved 5 November 2017.
- ^ "The first Sjöberg Prize, totalling 1 million US dollars, is awarded for discoveries that have led to new and effective cancer treatments". kva.se. Sweden: Royal Swedish Academy of Sciences. 14 February 2017. Retrieved 5 November 2017.
- ^ "2018's Sjöberg Prize awarded for unique treatment that cures a once fatal cancer". Royal Swedish Academy of Sciences. 5 February 2018. Retrieved 12 November 2018.
- ^ "Targeted treatment of cancer receives the Sjöberg Prize". kva.se. Retrieved 20 March 2019.
- ^ Laureates 2020
- ^ "New knowledge about a cancer pharmaceutical led to the Sjöberg Prize". Royal Swedish Academy of Sciences. Retrieved 16 December 2021.
- ^ "Discovery about a cause of prostate cancer rewarded with the Sjöberg Prize". Kungl. Vetenskapsakademien. 2022-02-14. Retrieved 2024-08-14.
- ^ "Sjöberg Laureate brings new hope to people with lung cancer". Kungl. Vetenskapsakademien. Retrieved 2023-02-15.
- ^ "Sjöberg Prize 2024". Kungl. Vetenskapsakademien. 2024-02-14. Retrieved 2024-08-14.